COVID-19
|
SUBSCRIBE
|
FAQs
HOME
ABOUT US
WHO WE ARE
THE SAHPRA BOARD
EXECUTIVE MANAGEMENT
REGULATORY PARTNERSHIP
SPECIAL PROJECTS
BACKLOG
VACANCIES
NEWS
LATEST NEWS & UPDATES
PRESS RELEASES
PRESENTATIONS
SAFETY ALERTS
UPCOMING EVENTS
WORKSHOPS AND CONFERENCES
SAHPRA TV
HEALTH PRODUCTS
ORTHODOX MEDICINES
GUIDELNES
TEMPLATES
BIOLOGICAL PRODUCTS
GUIDELINES
COMPLEMENTARY MEDICINES
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
TEMPLATES
MEDICAL DEVICES
APPLICATION FORMS
GUIDELINES
POSITION STATEMENTS
COMMUNICATION TO INDUSTRY
TEST KITS
RELATED DOCUMENTS
RADIATION CONTROL
ACTS AND REGULATIONS
APPLICATION AND REPORT FORMS
GUIDELNES AND CODES OF PRACTICE
UNREGISTERED PRODUCTS
GUIDELINES
VETERINARY MEDICINES
GUIDELNES
E-SERVICES
ACCESS TO UNREGISTERED HEALTH PODUCTS
NEW AUTHORIZATIONS
RE-AUTHORIZATIONS
ADVERSE DRUG REACTION REPORTING
COMPLEMENTARY MEDICINES LICENSING
COVI-VIG REPORTING SYSTEM
HEALTH PRODUCT APPLICATION STATUS CHECKER
PRODUCT VARIATIONS PORTAL
PUBLICATIONS
ACTS AND REGULATIONS
ANNUAL REPORT
CORPORATE IDENTITY
GOVERNMENT GAZETTES AND REGULATIONS
GUIDELINES
FEES
PRESENTATIONS
SAHPRA PLANNING DOCUMENTS
TENDERS
CONTACT US
HEAD OFFICE
KEY CONTACTS
MEDIA ENQUIRIES
FEEDBACK AND COMPLAINTS
HOME
ABOUT US
WHO WE ARE
THE SAHPRA BOARD
EXECUTIVE MANAGEMENT
REGULATORY PARTNERSHIP
SPECIAL PROJECTS
BACKLOG
VACANCIES
NEWS
LATEST NEWS & UPDATES
PRESS RELEASES
PRESENTATIONS
SAFETY ALERTS
UPCOMING EVENTS
WORKSHOPS AND CONFERENCES
SAHPRA TV
HEALTH PRODUCTS
ORTHODOX MEDICINES
GUIDELNES
TEMPLATES
BIOLOGICAL PRODUCTS
GUIDELINES
COMPLEMENTARY MEDICINES
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
TEMPLATES
MEDICAL DEVICES
APPLICATION FORMS
GUIDELINES
POSITION STATEMENTS
COMMUNICATION TO INDUSTRY
TEST KITS
RELATED DOCUMENTS
RADIATION CONTROL
ACTS AND REGULATIONS
APPLICATION AND REPORT FORMS
GUIDELNES AND CODES OF PRACTICE
UNREGISTERED PRODUCTS
GUIDELINES
VETERINARY MEDICINES
GUIDELNES
E-SERVICES
ACCESS TO UNREGISTERED HEALTH PODUCTS
NEW AUTHORIZATIONS
RE-AUTHORIZATIONS
ADVERSE DRUG REACTION REPORTING
COMPLEMENTARY MEDICINES LICENSING
COVI-VIG REPORTING SYSTEM
HEALTH PRODUCT APPLICATION STATUS CHECKER
PRODUCT VARIATIONS PORTAL
PUBLICATIONS
ACTS AND REGULATIONS
ANNUAL REPORT
CORPORATE IDENTITY
GOVERNMENT GAZETTES AND REGULATIONS
GUIDELINES
FEES
PRESENTATIONS
SAHPRA PLANNING DOCUMENTS
TENDERS
CONTACT US
HEAD OFFICE
KEY CONTACTS
MEDIA ENQUIRIES
FEEDBACK AND COMPLAINTS
Press
Press
Press Release EXEMPTION OF SOME PRODUCTS WHICH CONTAIN CANNABIDIOL FROM CERTAIN PROVISIONS OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965).
January 24, 2020
Press
Medicines Control Council alerts the public of the risks and harm associated with the inappropriate and non-prescribed use of testosterone-containing medicines
July 26, 2019
Press
MEDICINES CONTROL COUNCIL
July 19, 2019
